Overview


According to FutureWise analysis, the market for Interventional Radiology Products is expected to reach US$ 19.61 billion by 2031 at a CAGR of 6.82%.

The goal of interventional radiology is to diagnose and treat diseases using minimally-invasive imaging-guided techniques. Due to its many applications in diagnosing and treating a variety of diseases as well as technological advances, interventional radiology has expanded widely. The increasing incidence of chronic diseases such as blood vessel diseases and the development of new technologies such as Optical Coherence Tomography (OCT), and Fractional Flow Reserve (FFR) are the major factors driving this market. However, high equipment costs and the need for efficient handling techniques may hinder the growth of the market. A number of recent developments and the development of modified techniques create high growth opportunities for the market. The interventional radiology market is being driven by advancements in imaging technologies, which give surgeons a comprehensive view of internal organs as they diagnose. Augmented reality and artificial intelligence are major technological advances. Unlike virtual reality, where doctors cannot see real images, augmented reality allows them to move objects (scopes and devices) inside the body and interact with its surroundings. These dynamic developments have wide-ranging applications for image-led intervention. Using complex algorithms, artificial intelligence can detect abnormalities and anomalies in medical images, including CT scans and X-rays.

FutureWise Market Research has instantiated a report that provides an intricate analysis of Interventional Radiology Products Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.

According to the research study conducted by FutureWise research analysts, the Interventional Radiology Products Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.

A number of recent developments and the development of modified techniques create high growth opportunities for the market. The interventional radiology market is being driven by advancements in imaging technologies, which give surgeons a comprehensive view of internal organs as they diagnose. Augmented reality and artificial intelligence are major technological advances. Unlike virtual reality, where doctors cannot see real images, augmented reality allows them to move objects (scopes and devices) inside the body and interact with its surroundings. These dynamic developments have wide-ranging applications for image-led intervention. Using complex algorithms, artificial intelligence can detect abnormalities and anomalies in medical images, including CT scans and X-rays.

The rise in the number of research and development activities associated with interventional radiology and advancement in imaging technology will provide beneficial opportunities for the interventional radiology products market growth. Additionally, the increasing demand from emerging markets and the launch of new products will further expand the interventional radiology products market’s growth rate in the future.

  • Medtronic
  • Boston Scientific Corporation
  • Becton, Dickinson and Company
  • Abbott
  • Cardinal Health
  • B. Braun Melsungen AG
  • Stryker
  • Terumo Medical Corporation
  • Cook Medical
  • Biosensors International Group, Ltd.
  • Teleflex Incorporated
  • iVascular S.L.U.
  • Penumbra, Inc.
  • BIOTRONIK SECo. KG
  • ENDOCOR GmbH
  • Meril Life Sciences Pvt. Ltd.
  • Palex Medical
  • UreSil, LLC.
  • Alvimedica
  • Cardionovum GmbH
  • SMT
  • Medinol Ltd.
  • Comed B.V.
  • SCITECH
  • Balton Sp. z o.o.
  • Rontis

(Note: The list of the major players will be updated with the latest market scenario and trends)

By Type

  • Catheters
  • Stents
  • Inferior Vena Cava (IVC) Filters
  • Hemodynamic Flow Alteration Devices
  • Angioplasty Balloons
  • Thrombectomy Systems
  • Embolization Devices
  • Biopsy Needles
  • Accessories
  • Other Interventional Radiology Products

By Procedure

  • Angioplasty
  • Angiography
  • Embolization
  • Thrombolysis
  • Biopsy and Drainage
  • Vertebroplasty
  • Nephrostomy
  • Other Procedures

By Application

  • Cardiology
  • Urology and Nephrology
  • Oncology
  • Gastroenterology
  • Neurology
  • Orthopedics
  • Other Applications

By Region

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa


  • Tier 1 players- established companies in the market with a major market share
  • Tier 2 players
  • Emerging players which are growing rapidly
  • New Entrants

  • Growth prospects
  • SWOT analysis
  • Key trends
  • Key data-points affecting market growth

  • To provide with an exhaustive analysis on the Interventional Radiology Products Market By Type, By Procedure, By Application and By Region.
  • To cater comprehensive information on factors impacting market growth (drivers, restraints, opportunities, and industry-specific restraints)
  • To evaluate and forecast micro-markets and the overall market
  • To predict the market size, in key regions— North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
  • To record and evaluate competitive landscape mapping- product launches, technological advancements, mergers and expansions

  • We have a flexible delivery model and you can suggest changes in the scope/table of content as per your requirement
  • The customization Mobility Care offered are free of charge with purchase of any license of the report
  • You can directly share your requirements/changes to the current table of content to: sales@futurewiseresearch.com

Table of Contents


  • 1.   Market Introduction
    •   1. Objectives of the Study
        2. Market Definition
        3. Market Scope
         3.1. Years Considered for the Study
         3.2. Market Covered
        4. Currency
        5. Limitations
        6. Stakeholders
  • 2.   Research Methodology
    •   1. Research Data
         1.1. Secondary Data
          1.1.1. Key Data from Secondary Sources
         1.2. Primary Data
          1.2.1. Key Data from Primary Sources
        2. Market Size Estimation
        3. Market Breakdown and Data Triangulation
        4. Assumptions for the Study
  • 3.   Executive Summary
    •   1. Market Outlook
        2. Segment Outlook
        3. Competitive Insights
  • 4.   Interventional Radiology Products Market Variables, Trends and Scope
    •   1. Market Lineage Outlook
        2. Penetration and Growth Prospect Mapping
        3. Industry Value Chain Analysis
        4. Cost Analysis Breakdown
        5. Technology Overview
        6. Regulatory Framework
         6.1. Reimbursement Framework
         6.2. Standards and Compliances

  • 5.   Market Overview
    •   1. Market Dynamics
         1.1. Market Driver Analysis
          1.1.1. Increasing focus of Interventional Radiology Products Market Companies on Brand Protection
          1.1.2. Untapped Opportunities in Emerging Regions
         1.2. Market Restraint Analysis
          1.2.1. High Cost Associated with Implementation of Predictive Analysis
         1.3. Industry Challenges
          1.3.1. Presence of Ambiguous Regulatory Framework
  • 6.   Interventional Radiology Products Market Analysis Tools
    •   1. Industry Analysis - Porter’s
         1.1. Supplier Power
         1.2. Buyer Power
         1.3. Substitution Threat
         1.4. Threat from New Entrants
         1.5. Competitive Rivalry
        2. Pestel Analysis
         2.1. Political Landscape
         2.2. Environmental Landscape
         2.3. Social Landscape
         2.4. Technology Landscape
         2.5. Legal Landscape
        3. Major Deals And Strategic Alliances Analysis
         3.1. Joint Ventures
         3.2. Mergers and Acquisitions
         3.3. Licensing and Partnership
         3.4. Technology Collaborations
         3.5. Strategic Divestments
        4. Market Entry Strategies
        5. Case Studies
  • 7.   Interventional Radiology Products Market, By Type Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Catheters
        2. Stents
        3. Inferior Vena Cava (IVC) Filters
        4. Hemodynamic Flow Alteration Devices
        5. Angioplasty Balloons
        6. Thrombectomy Systems
        7. Embolization Devices
        8. Biopsy Needles
        9. Accessories
        10. Other Interventional Radiology Products

  • 8.   Interventional Radiology Products Market, By Procedure Historical Analysis and Forecast 2023-2031 (USD Million)
    •   1. Angioplasty
        2. Angiography
        3. Embolization
        4. Thrombolysis
        5. Biopsy and Drainage
        6. Vertebroplasty
        7. Nephrostomy
        8. Other Procedures

  • 9.   Interventional Radiology Products Market, By Application Historical Analysis and Forecast 2017-2022 (USD Million)
    •   1. Cardiology
        2. Urology and Nephrology
        3. Oncology
        4. Gastroenterology
        5. Neurology
        6. Orthopedics
        7. Other Applications

  • 10.   North America Interventional Radiology Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. U.S.A
         2.2. Canada
         2.3. Mexico
        3. Market Size (USD Million) Forecast for North America 2023-2031

  • 11.   Latin America Interventional Radiology Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Brazil
         2.2. Venezuela
         2.3. Argentina
         2.4. Rest of Latin America
        3. Market Size (USD Million) Forecast for Latin America 2023-2031

  • 12.   Europe Interventional Radiology Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Germany
         2.2. U.K
         2.3. France
         2.4. Italy
         2.5. Spain
         2.6. Russia
         2.7. Poland
         2.8. Rest of Europe
        3. Market Size (USD Million) Forecast for Europe 2023-2031

  • 13.   Asia Pacific Interventional Radiology Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. Japan
         2.2. China
         2.3. India
         2.4. Australia and New Zealand
         2.5. ASEAN
         2.6. Rest of Asia Pacific
        3. Market Size (USD Million) Forecast for Asia Pacific 2023-2031

  • 14.   Middle East and Africa Interventional Radiology Products Market Analysis 2017-2022 and Forecast 2023-2031 (USD Million)
    •   1. Introduction
        2. Historical Market Size (USD Million) Analysis By Country, 2017-2022
         2.1. GCC
         2.2. Israel
         2.3. South Africa
         2.4. Rest of MEA
        3. Market Size (USD Million) Forecast for MEA 2023-2031

  • 15.   Market Share Analysis and Competitive Landscape
    •   1. Global Landscape - Key Players, Revenue and Presence
        2. Global Share Analysis - Key Players (Tier 1, Tier 2, Tier 3)
        3. Global Emerging Companies
        4. North America - Market Share Analysis and Key Regional Players
        5. Europe - Market Share Analysis and Key Regional Players
        6. Asia Pacific - Market Share Analysis and Key Regional Players
        7. Global Key Player - Growth Matrix
  • 16.   Company Profiles (Competition Dashboard, Competitors Deep Dive, Products Offered and Financial Layouts)
    •   1. Medtronic
         1.1. Company Overview
         1.2. Product Portfolio
         1.3. SWOT Analysis
         1.4. Financial Overview
         1.5. Strategic Overview
        2. Boston Scientific Corporation
         2.1. Company Overview
         2.2. Product Portfolio
         2.3. SWOT Analysis
         2.4. Financial Overview
         2.5. Strategic Overview
        3. Becton, Dickinson and Company
         3.1. Company Overview
         3.2. Product Portfolio
         3.3. SWOT Analysis
         3.4. Financial Overview
         3.5. Strategic Overview
        4. Abbott
         4.1. Company Overview
         4.2. Product Portfolio
         4.3. SWOT Analysis
         4.4. Financial Overview
         4.5. Strategic Overview
        5. Cardinal Health
         5.1. Company Overview
         5.2. Product Portfolio
         5.3. SWOT Analysis
         5.4. Financial Overview
         5.5. Strategic Overview
        6. B. Braun Melsungen AG
         6.1. Company Overview
         6.2. Product Portfolio
         6.3. SWOT Analysis
         6.4. Financial Overview
         6.5. Strategic Overview
        7. Stryker
         7.1. Company Overview
         7.2. Product Portfolio
         7.3. SWOT Analysis
         7.4. Financial Overview
         7.5. Strategic Overview
        8. Terumo Medical Corporation
         8.1. Company Overview
         8.2. Product Portfolio
         8.3. SWOT Analysis
         8.4. Financial Overview
         8.5. Strategic Overview
        9. Cook Medical
         9.1. Company Overview
         9.2. Product Portfolio
         9.3. SWOT Analysis
         9.4. Financial Overview
         9.5. Strategic Overview
        10. Biosensors International Group, Ltd.
         10.1. Company Overview
         10.2. Product Portfolio
         10.3. SWOT Analysis
         10.4. Financial Overview
         10.5. Strategic Overview
        11. Teleflex Incorporated
         11.1. Company Overview
         11.2. Product Portfolio
         11.3. SWOT Analysis
         11.4. Financial Overview
         11.5. Strategic Overview
        12. iVascular S.L.U.
         12.1. Company Overview
         12.2. Product Portfolio
         12.3. SWOT Analysis
         12.4. Financial Overview
         12.5. Strategic Overview
        13. Penumbra, Inc.
         13.1. Company Overview
         13.2. Product Portfolio
         13.3. SWOT Analysis
         13.4. Financial Overview
         13.5. Strategic Overview
        14. BIOTRONIK SECo. KG
         14.1. Company Overview
         14.2. Product Portfolio
         14.3. SWOT Analysis
         14.4. Financial Overview
         14.5. Strategic Overview
        15. ENDOCOR GmbH
         15.1. Company Overview
         15.2. Product Portfolio
         15.3. SWOT Analysis
         15.4. Financial Overview
         15.5. Strategic Overview
        16. Meril Life Sciences Pvt. Ltd.
         16.1. Company Overview
         16.2. Product Portfolio
         16.3. SWOT Analysis
         16.4. Financial Overview
         16.5. Strategic Overview
        17. Palex Medical
         17.1. Company Overview
         17.2. Product Portfolio
         17.3. SWOT Analysis
         17.4. Financial Overview
         17.5. Strategic Overview
        18. UreSil, LLC.
         18.1. Company Overview
         18.2. Product Portfolio
         18.3. SWOT Analysis
         18.4. Financial Overview
         18.5. Strategic Overview
        19. Alvimedica
         19.1. Company Overview
         19.2. Product Portfolio
         19.3. SWOT Analysis
         19.4. Financial Overview
         19.5. Strategic Overview
        20. Cardionovum GmbH
         20.1. Company Overview
         20.2. Product Portfolio
         20.3. SWOT Analysis
         20.4. Financial Overview
         20.5. Strategic Overview
        21. SMT
         21.1. Company Overview
         21.2. Product Portfolio
         21.3. SWOT Analysis
         21.4. Financial Overview
         21.5. Strategic Overview
        22. Medinol Ltd.
         22.1. Company Overview
         22.2. Product Portfolio
         22.3. SWOT Analysis
         22.4. Financial Overview
         22.5. Strategic Overview
          23. Comed B.V.
          23.1. Company Overview
          23.2. Product Portfolio
          23.3. SWOT Analysis
          23.4. Financial Overview
          23.5. Strategic Overview
         24. SCITECH
          24.1. Company Overview
          24.2. Product Portfolio
          24.3. SWOT Analysis
          24.4. Financial Overview
          24.5. Strategic Overview
        25. Balton Sp. z o.o.
         25.1. Company Overview
         25.2. Product Portfolio
         25.3. SWOT Analysis
         25.4. Financial Overview
         25.5. Strategic Overview
        26. Rontis
         26.1. Company Overview
         26.2. Product Portfolio
         26.3. SWOT Analysis
         26.4. Financial Overview
         26.5. Strategic Overview

  • 17.   Pre and Post COVID-19 Impact
    •   1. Positive influence on the healthcare industry
        2. The financial disruption of the manufacturing sector
        3. Impact of COVID-19 on emerging companies
        4. Significant mandates in the regulations initiated by healthcare administrations
        5. The overall economic slowdown of the developing and developed nations
  • 18.   FutureWise SME Key Takeaway Points for Client
Partner

Our Clients